Current guidelines for high-density lipoprotein cholesterol in therapy and future directions

Many studies have suggested that a significant risk factor for atherosclerotic cardiovascular disease (ASCVD) is low high-density lipoprotein cholesterol (HDL-C). Therefore, increasing HDL-C with therapeutic agents has been considered an attractive strategy. In the prestatin era, fibrates and niacin...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Subedi, Bishnu H, Joshi, Parag H, Jones, Steven R, Martin, Seth S, Blaha, Michael J, Michos, Erin D
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2014
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3986285/
https://ncbi.nlm.nih.gov/pubmed/24748800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S45648
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki